CVS Health Corp.
first-quarter sales rose more than 11% as the pharmacy chain continued to benefit from administering Covid-19 vaccines and selling at-home tests.
The Woonsocket, R.I.-based company said Wednesday that it expects demand for Covid testing and vaccines to lift sales throughout 2023.
“Many like to model Covid going to zero for retail, and that’s a convenient modeling assumption, but I think a very highly unlikely outcome for 2023 as we move from pandemic to endemic,” CVS Chief Financial Officer
Shawn Guertin
said on a call with analysts.
CVS said Wednesday that it administered more than six million Covid-19 tests and over eight million Covid vaccines in the first three months of the year.
Demand for Covid-19 testing surged…
